Evidence map›Paper›PMID 35493059›Full record

ArticleArthroscopy techniques2022

Knee Medial Collateral Ligament Augmentation With Bioinductive Scaffold: Surgical Technique and Indications.

Matthew R LeVasseur, Colin L Uyeki, Patrick Garvin, Sean McMillan, Robert A Arciero

Open access · goldAbstract read
In one paragraph

Article in Arthroscopy techniques, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. [Diagnosis and treatment progress in the femoral insertion injury of medial collateral ligament of knee].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2023
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Matthew R LeVasseurDepartment of Orthopaedic Surgery, University of Connecticut, Farmington, Connecticut, U.S.A.
Colin L UyekiDepartment of Orthopaedic Surgery, University of Connecticut, Farmington, Connecticut, U.S.A.
Patrick GarvinDepartment of Orthopaedic Surgery, University of Connecticut, Farmington, Connecticut, U.S.A.
Sean McMillanDepartment of Orthopaedic Surgery, Virtua Health, Burlington, New Jersey, U.S.A.
Robert A ArcieroDepartment of Orthopaedic Surgery, University of Connecticut, Farmington, Connecticut, U.S.A.
University of Connecticut · USVirtua Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The medial collateral ligament (MCL) is the most commonly injured ligament of the knee; however, only a minority of cases require surgical intervention. Classically, isolated grade I and II MCL injuries are treated nonoperatively whereas isolated grade III injuries may be treated with surgery. High-grade MCL injuries are frequently associated with concomitant knee ligamentous injuries, particularly the anterior cruciate ligament. Nonetheless, MCL repair or reconstruction is generally reserved for patients with persistent valgus instability after failed nonoperative management. Synthetic and biological implants are increasing in popularity to augment repairs and reconstructions for biomechanical reinforcement and promotion of the native healing response to hasten rehabilitation. The BioBrace (Biorez, New Haven, CT) is a bioinductive scaffold composed of highly porous type I collagen and bioresorbable poly(L-lactide) microfilaments, providing an environment for soft-tissue regeneration and mechanical support. The purpose of this article is to describe the surgical technique and relative indications for the BioBrace in knee MCL ligament repairs and reconstructions.

Identifiers

PMID35493059
PMCPMC9051886
OpenAlexW4220863539

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.